Delivery Order SPE2DE24D0013-SPE2D625F6WY0

The U.S. Defense Department's Medical Supply Chain division awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a discrete procurement action for molecular diagnostic solutions, consistent with Cepheid's core business of manufacturing diagnostic testing systems and reagents for infectious diseases including COVID-19, influenza, and other pathogens.

This award is likely associated with one of Cepheid's larger Indefinite Delivery Vehicle contracts with the Veterans Administration, which serve as the underlying procurement vehicles for such delivery orders. Cepheid maintains significant IDV agreements with VA networks valued at tens of millions of dollars, enabling the continuous supply of molecular diagnostic testing systems and reagents to federal healthcare facilities. The company's established track record with the Defense Health Agency and other Department of Defense entities positions it as a key supplier of diagnostic capabilities across the federal healthcare system, with this particular order fulfilling near-term testing requirements for the Medical Supply Chain program.